XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.2
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS (Tables)
6 Months Ended
Jun. 30, 2025
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS  
Schedule of stock were valued on the date of issuance using the Monte Carlo pricing model with the following assumptions

    

Series A Right Warrant

    

Series B Right Warrant

Common Stock Price as of Issuance Date

$

0.94

$

0.94

Risk-Free Rate

4.31

%

 

4.27

%

Dividend Rate

0.00

%

 

0.00

%

Volatility

88.90

%

 

97.19

%

Minimum Exercise Price

$

1.00

$

2.00

Maximum Exercise Price

$

2.00

$

4.00

Formula for Exercise Price

90% of the 5-day volume weighted average stock price as of the exercise date rounded down to the nearest cent, not to fall outside the range of the maximum and minimum exercise prices.

Schedule of stock-based compensation expense

    

Three Months Ended June 30,

Stock-based compensation expense by category

2025

2024

(amounts, in thousands)

Cost of goods sold

$

32

$

Research and development, net of grant income

 

110

 

Selling, general and administrative

 

429

989

Total stock-based compensation expense

$

571

$

989

    

Six Months Ended June 30, 

Stock-based compensation expense by category

2025

    

2024

(amounts, in thousands)

Cost of goods sold

$

88

$

Research and development, net of grant income

247

Selling, general and administrative

 

1,056

 

1,949

Total stock-based compensation expense

$

1,391

$

1,949

Schedule of stock options activity

Weighted

Weighted

Average

Average

Remaining

Exercise Price

Contractual

    

Shares

    

per Share

    

Life (Years)

Outstanding, December 31, 2024

 

12,341,907

$

3.55

6.81

Granted

 

144,500

1.02

 

Forfeited

 

(97,514)

2.17

 

Expired

 

(187,177)

6.64

 

Outstanding, June 30, 2025

 

12,201,716

$

3.48

 

6.41

Schedule of fair value of each stock option estimated using the Black-Scholes pricing model

The Company estimated the fair value of stock options granted during the six months ended June 30, 2025 using a Black-Scholes pricing model, which used the following inputs:

Exercise price (per share)

$

0.82 - $1.30

Expected volatility

 

80.7

%

Expected term*

 

6.2 years

Risk-free rate

 

3.89% - 4.40

%

Dividends

 

0

%

*The expected term of the options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The simplified method is used as the Company’s employee exercise history may not be indicative for estimating future exercises. In addition, the Company recognizes forfeitures as they occur.

Schedule of intrinsic value

The intrinsic value is calculated as the difference between the market value of the shares as of June 30, 2025 of $1.28 and the exercise price of the shares.

Options Outstanding

Number

Weighted

Weighted

Aggregate

Range of

Outstanding at

Average

Average

Intrinsic

Exercise

June 30, 

Exercise

Remaining

Value

Price

    

2025

    

Price

    

Life (Years)

    

(in thousands)

$0.82 - $13.20

 

12,201,716

$

3.48

6.41

$

1,064

Options Exercisable

Number

Weighted

Aggregate

Exercisable at

Average

Intrinsic

June 30, 

Exercise

Value

2025

    

Price

    

(in thousands)

8,249,409

$

4.24

$

702

Schedule of company's non-vested options

Weighted

Average

Grant Date

    

Shares

    

Fair Value

Non-vested, December 31, 2024

 

6,234,550

$

1.09

Granted

 

144,500

$

1.02

Forfeited

 

(97,514)

$

2.17

Vested

 

(2,329,220)

$

0.80

Non-vested, June 30, 2025

 

3,952,316

$

1.24

Schedule of outstanding balance of restricted stock units

Total

Intrinsic Value

(amounts in thousands, except share data)

Outstanding, December 31, 2024

 

2,809,500

 

$

2,557

Granted

 

97,500

 

Vested

(35,000)

Forfeited

 

(39,500)

 

Outstanding, June 30, 2025

 

2,832,500

$

3,626

Schedule of the restricted stock unit activity

Weighted

Average

Grant Date

    

Shares

    

Fair Value

Non-vested, January 1, 2025

 

641,335

$

1.31

Granted

110,000

1.04

Vested

 

(139,000)

0.96

Unvested shares forfeited

(65,000)

0.96

Non-vested, June 30, 2025

 

547,335

$

1.39